Look for:

Our offer for

ECKERT & ZIEGLER SE


ISIN:
DE0005659700
WKN:
565970
2024/05/24 17:35:22
Price
46.20 EUR
Difference 0.92% (0.42)

General attributes

ISINDE0005659700
SymbolEUZ
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)963 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open45.50 EUR
High46.34 EUR
Low45.50 EUR
Close (prev. day)45.78 EUR
VWAP45.99466 EUR
Volume (pcs)55,340
Trading volume2,545,344.68
Number of trades915
Last size15,504

PDF Downloads

Company report: ECKERT & ZIEGLER SEPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/24 17:35:22
Price
46.20 EUR
Difference 0.92% (0.42)

General attributes

ISINDE0005659700
SymbolEUZ
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)963 EUR
BenchmarkGERMANY DAX
-
-
45,50 EUR
46,34 EUR
45,50 EUR
45,78 EUR
45,99466 EUR
55.340
2.545.344,68
915
15.504

Performance and Risk

6m1Y3Y
Perf (%)+18.64%+4.05%-45.71%
Perf (abs.)+7.26+1.80-38.90
Beta1.261.471.43
Volatility41.1940.3248.30
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

46,34 EUR (40.065)
39,73 EUR (58.476)
40,60 EUR (57.191)
37,54 EUR (56.195)
47,32 EUR (16.05.2024)
32,74 EUR (19.04.2024)
47,32 EUR (16.05.2024)
28,92 EUR (13.09.2023)

ECKERT & ZIEGLER SE

 
Xetra24.05.202417:3546,20 EUR2,55915
Tradegate24.05.202422:2646,12 EUR0,3174
Stuttgart24.05.202421:5546,06 EUR0,1578
Munich24.05.202408:0145,62 EUR0,001
London Stock Exchange European Trade Reporting24.05.202417:3045,83 EUR0,002
Hanover24.05.202408:1645,38 EUR0,003
Hamburg24.05.202408:1645,38 EUR0,003
Frankfurt24.05.202408:0245,38 EUR0,002
Euronext Milan MTF Trading After Hours24.05.202417:4445,98 EUR0,001
Euronext Milan MTF Global Equity Market24.05.202417:4445,98 EUR0,001
Duesseldorf24.05.202419:3145,84 EUR0,007
Berlin24.05.202421:5246,08 EUR0,0017

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=967&ID_TYPE_IMAGE_LOGO=2

Contact Details

ECKERT & ZIEGLER SE
- -
Robert-Rössle-Strasse 10 - 13125 Berlin
Telefon: +49-30-94-10-84-0
Fax: +49-30-94-10-84-112
E-mail: info@ezag.de

PDF Downloads

Company report: ECKERT & ZIEGLER SEPDF Download

Company Profile

Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Harald HasselmannChairman of Managing Board
Franklin YeagerMember of Executive Committee
Jutta LudwigMember of Executive Committee

Board of directors

Andreas EckertChairman of Supervisory Board
Edgar LöfflerMember of Supervisory Board
Helmut GrotheMember of Supervisory Board
Albert RupprechtMember of Supervisory Board
Frank PerschmannMember of Supervisory Board
Paola Eckert-PalvariniMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer